References
- Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67.
- Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med 1983;98:504-13. https://doi.org/10.7326/0003-4819-98-4-504
- Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72:153-84. https://doi.org/10.1097/00000542-199001000-00025
- Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297: 845-50. https://doi.org/10.1056/NEJM197710202971601
- Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery: a multifactorial clinical risk index. Arch Intern Med 1986;146:2131-4. https://doi.org/10.1001/archinte.1986.00360230047007
- Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. https://doi.org/10.1161/01.CIR.100.10.1043
- Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94. https://doi.org/10.1056/NEJM199912093412402
- Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66. https://doi.org/10.7326/0003-4819-110-11-859
- Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT. Echocardiography for assessing cardiac risk in patients having noncardiac surgery: Study of Perioperative Ischemia Research Group. Ann Intern Med 1996;125:433-41. https://doi.org/10.7326/0003-4819-125-6-199609150-00001
- Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006;113:1361-76. https://doi.org/10.1161/CIRCULATIONAHA.105.573113
- McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971; 285:1441-6. https://doi.org/10.1056/NEJM197112232852601
- Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. Nterminal- pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74. https://doi.org/10.1161/01.CIR.0000144310.04433.BE
- Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) In vestigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-12. https://doi.org/10.1161/01.CIR.0000147611.92021.2B
- Goei D, van Kuijk JP, Flu WJ, et al. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery. Am J Cardiol 2011;107:609-14. https://doi.org/10.1016/j.amjcard.2010.10.021
- Schutt RC, Cevik C, Phy MP. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in highrisk patients undergoing noncardiac surgery. Am J Cardiol 2009;104: 137-40. https://doi.org/10.1016/j.amjcard.2009.03.005
- Goei D, Hoeks SE, Boersma E, et al. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coron Artery Dis 2009;20:219-24. https://doi.org/10.1097/MCA.0b013e3283219e47
- Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321. https://doi.org/10.1053/pcad.2002.24599
- Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995;96: 1280-7. https://doi.org/10.1172/JCI118162
- Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75. https://doi.org/10.1056/NEJMoa042330
- De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of Btype natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21. https://doi.org/10.1056/NEJMoa011053
- Leibowitz D, Planer D, Rott D, Elitzur Y, Chajek-Shaul T, Weiss AT. Brain natriuretic peptide levels predict perioperative events in cardiac patients undergoing noncardiac surgery: a prospective study. Cardiology 2008;110:266-70. https://doi.org/10.1159/000112411
- Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006;92: 1645-50. https://doi.org/10.1136/hrt.2005.085530
- Berry C, Kingsmore D, Gibson S, et al. Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery. Heart 2006;92:401-2.
- Cuthbertson BH, Amiri AR, Croal BL, et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007;99:170-6. https://doi.org/10.1093/bja/aem158
- Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Brittenden J, Hillis GS. Utility of B-type natriuretic peptide in predicting medium-term mortality in patients undergoing major non-cardiac surgery. Am J Cardiol 2007;100:1310-3. https://doi.org/10.1016/j.amjcard.2007.05.058
- Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004;43:1873-9. https://doi.org/10.1016/j.jacc.2003.12.048
Cited by
- Postoperative B-type Natriuretic Peptide for Prediction of Major Cardiac Events in Patients Undergoing Noncardiac Surgery: Systematic Review and Individual Patient Meta-analysis vol.119, pp.2, 2012, https://doi.org/10.1097/aln.0b013e31829083f1
- Restrictive Deferred Hydration Combined with Preemptive Norepinephrine Infusion during Radical Cystectomy Reduces Postoperative Complications and Hospitalization Time: A Randomized Clinical Trial vol.120, pp.2, 2012, https://doi.org/10.1097/aln.0b013e3182a44440
- The Effect of Anesthesia Method on Serum Level of Pro-Brain Natriuretic Peptide in Patients Undergoing Orthopedic Surgery vol.5, pp.2, 2012, https://doi.org/10.5812/aapm.19707
- B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery : vol.16, pp.6, 2015, https://doi.org/10.2459/jcm.0000000000000210
- Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility vol.10, pp.3, 2012, https://doi.org/10.2217/bmm.16.1
- Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility vol.10, pp.3, 2012, https://doi.org/10.2217/bmm.16.1
- In-Hospital Postoperative Pneumonia Following Geriatric Intertrochanteric Fracture Surgery: Incidence and Risk Factors vol.15, pp.None, 2012, https://doi.org/10.2147/cia.s268118